The Senior Director, Global Commercial, panKRAS will lead the global commercial strategy for AstraZeneca’s clinical-stage, oral, multi-target KRAS inhibitor, a priority asset within the GI Oncology portfolio. The role will shape the asset’s commercial potential from an early stage, providing strategic and commercial input to development priorities, evidence generation and investment decisions. It will translate patient, customer, market and competitive insights into choices on indication prioritisation, patient populations, target product profile, differentiation and sequencing, and establish the foundation for future launch excellence, including preparations for the lead indication. As part of the Global IO Commercial Franchise Team, the role works closely with Clinical Development, Global Medical Affairs, Regulatory Affairs, Diagnostics, Pricing and Market Access, Global Analytics & Insights, Digital, Corporate Affairs, regional and country teams, and other partners. It is accountable for differentiated strategy and positioning, deep customer and market insights, commercial input to development and investment decisions, market-shaping programmes, and commercial planning through launch and beyond. The role also represents Global Commercial in cross-functional teams and governance forums to ensure development choices reflect future patient, customer and market needs. The position leads global brand strategy and planning; launch strategy, readiness and execution across priority markets; agency and vendor relationships; brand budgets, forecasts and resource allocation; performance measurement; and senior leadership updates. It proactively manages strategic, operational, regulatory and reputational risks and ensures activities comply with applicable policy, legal, regulatory and industry requirements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior